| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/18/2011 | CN102061306A Preparation method and application of immunomodulatory peptide |
| 05/18/2011 | CN102060934A Enzymatic extraction method for auricularia auricula polysaccharides |
| 05/18/2011 | CN102060929A T-cell immune balance peptide |
| 05/18/2011 | CN102060916A Enterotoxin C2 superantigen mutant proteins, and coding gene and preparation and application thereof |
| 05/18/2011 | CN102060903A Ginsenoside Rh2 extractive and preparation method thereof |
| 05/18/2011 | CN102060857A Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/18/2011 | CN102060843A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 05/18/2011 | CN102060842A 3-(substituted xylylenimine-2-yl)-2,6-piperidine diketone polymorph and medical composition |
| 05/18/2011 | CN102060806A Cytokine inhibitors |
| 05/18/2011 | CN102058884A Grass carp injection vaccine synergist and preparation method thereof |
| 05/18/2011 | CN102058871A Chinese medicine effective part composition with antitumor effect and preparation method thereof |
| 05/18/2011 | CN102058852A Medicinal liquor for treating cancer and preparation method thereof |
| 05/18/2011 | CN102058788A Extraction process for total flavonoids in wheat germ |
| 05/18/2011 | CN102058758A Application of garlic alkenyl ether in preparing medicines for regulating human immunity |
| 05/18/2011 | CN102058744A Chinese medicinal composition for treating malignant tumor and preparation method thereof |
| 05/18/2011 | CN102058731A Preparation of chaste tree twig leaf and fruit extract and anti-inflammatory medical application thereof |
| 05/18/2011 | CN102058728A Medicament with raw materials containing red tea and truffle |
| 05/18/2011 | CN102058695A Chinese medicine composition as well as preparation method and application thereof |
| 05/18/2011 | CN102058663A Clathrate compound formed by Salvia miltiorrhiza Bunge and cyclodextrin and application thereof |
| 05/18/2011 | CN102058648A Medicinal composition for improving immunity |
| 05/18/2011 | CN102058631A Seabuckthorn leaf extract preparation and preparation method thereof |
| 05/18/2011 | CN102058625A High-efficient anti-stress agent for aquaculture |
| 05/18/2011 | CN102058614A Use of adenosine receptor agonists in therapy |
| 05/18/2011 | CN102058547A Freeze-dried preparation |
| 05/18/2011 | CN102058546A Freeze-drying preparation for recombinant swine alpha-interferon and preparation method and usage thereof |
| 05/18/2011 | CN102058530A Ganoderma lucidum polysaccharide oral nanoemulsion and preparation method thereof |
| 05/18/2011 | CN101632669B Method of using diketopiperazines and composition containing them |
| 05/18/2011 | CN101549010B A preparing method and application of malaytea scurfpea fruit total glycosides extract |
| 05/18/2011 | CN101404996B Composition containing lignan compound |
| 05/18/2011 | CN101311165B Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 05/18/2011 | CN101242829B Pharmaceutical composition comprising PPAR regulator |
| 05/18/2011 | CN101186611B Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/18/2011 | CN101139554B Solid-state fermentation preparing method for Chinese herbal medicine yeast selenium |
| 05/18/2011 | CN101129441B Rhodiola rosea capsule and its preparing method |
| 05/18/2011 | CN101072875B Novel cancer antigen peptide and the use thereof |
| 05/17/2011 | US7943757 RNA interference mediated inhibition of intercellular adhesion molecule (ICAM) gene expression using short interfering nucleic acid (siNA) |
| 05/17/2011 | US7943635 Farnesyl-protein transferase inhibitors |
| 05/17/2011 | US7943627 2,4-diaminopyrimidine derivatives |
| 05/17/2011 | US7943624 Pyridinylpyrazolopyrimidinone derivatives as PDE 7 inhibitors |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943587 Administering to the individual, one or more nucleic acid molecules that comprise a nucleotide sequence that encodes an immunogen and a nucleotide sequence that encodes an Major Histocompatibility Complex antigen |
| 05/17/2011 | US7943583 2-O-(β-D-glucopyranosyl) ascorbic acid, process for its production, and foods cosmetics containing compositions comprising it |
| 05/17/2011 | US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 05/17/2011 | US7943571 Modified proteins, designer toxins, and methods of making thereof |
| 05/17/2011 | US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/17/2011 | US7943338 Autoimmune conditions and NADPH oxidase defects |
| 05/17/2011 | US7943332 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943153 Vaccines for Mycoplasma bovis and methods of use |
| 05/17/2011 | US7943151 Immunizing compositions and methods of use |
| 05/17/2011 | US7943150 Immunizing compositions and methods of use |
| 05/17/2011 | CA2560844C Pharmaceutical agent containing hyaluronan as an active ingredient |
| 05/17/2011 | CA2498944C Amino alcohol derivatives, salts thereof and immunosuppressive agents |
| 05/17/2011 | CA2487840C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and their therapeutic application |
| 05/17/2011 | CA2484374C Medical products comprising a haemocompatible coating, production and use thereof |
| 05/17/2011 | CA2451521C Use of poly-glu, tyr for neuroprotective therapy |
| 05/17/2011 | CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 05/17/2011 | CA2411642C Use of ingenanes for the activation of latent virus infection |
| 05/17/2011 | CA2391923C Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 05/17/2011 | CA2333582C Nicotine immunogen |
| 05/17/2011 | CA2308007C Enhancer for antibody to lymphocytic tumors |
| 05/12/2011 | WO2011057148A1 Compounds and compositions as tlr-7 activity modulators |
| 05/12/2011 | WO2011056652A1 Imidazole derivatives as ido inhibitors |
| 05/12/2011 | WO2011055843A1 Retinoid compound |
| 05/12/2011 | WO2011055561A1 Protein crosslinking inhibitor and use thereof |
| 05/12/2011 | WO2011055550A1 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 05/12/2011 | WO2011055215A2 Novel kinase modulators |
| 05/12/2011 | WO2011054939A2 Compositions and methods for inhibiting expression of kif10 genes |
| 05/12/2011 | WO2011054848A1 Thetrahydroquinolines derivatives as bromodomain inhibitors |
| 05/12/2011 | WO2011054846A1 Imidazo [4, 5-c] quinoline derivates as bromodomain inhibitors |
| 05/12/2011 | WO2011054530A1 Gpbp inhibition using q2 peptidomimetics |
| 05/12/2011 | WO2011054315A1 Use of cyr61 protein for preparing medicine |
| 05/12/2011 | WO2011054301A1 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder |
| 05/12/2011 | WO2011054100A1 Stem cell extracts and uses thereof for immune modulation |
| 05/12/2011 | WO2010150233A3 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof |
| 05/12/2011 | WO2010147898A3 Small molecule inhibitors of spleen tyrosine kinase (syk) |
| 05/12/2011 | US20110112283 Rna interference mediating small rna molecules |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112199 Pharmaceutical for oral delivery comprising mgbg and methods of treating disease |
| 05/12/2011 | US20110112193 Bis-aryl compounds for use as medicaments |
| 05/12/2011 | US20110112151 Compound capable of inhibiting 11-beta hydroxysteriod dehydrogenase |
| 05/12/2011 | US20110112146 Chromene modulators of chemokine receptor activity |
| 05/12/2011 | US20110112141 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 05/12/2011 | US20110112134 Tricyclic Antagonists of Prostaglandin D2 Receptors |
| 05/12/2011 | US20110112127 Compounds and methods for kinase modulation, and indications therefor |
| 05/12/2011 | US20110112112 Apogossypolone derivatives as anticancer agents |
| 05/12/2011 | US20110112098 Molecules inhibiting a metabolic pathway involving the syk protein tyrosine kinase and method for identifying said molecules |
| 05/12/2011 | US20110112092 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 05/12/2011 | US20110112091 Derivatives of tetrabromobenzimidazole, a process for the preparation thereof, a pharmaceutical composition comprising the same, a methof of using the same, a method for modulating or regulating serine/threonine kinases, and serine/threonine kinases modulating agent |
| 05/12/2011 | US20110112090 Depsipeptides and Their Therapeutic Use |
| 05/12/2011 | US20110112089 Cysteine Protease Inhibitors |
| 05/12/2011 | US20110112079 Phosphodiesterase inhibitors |
| 05/12/2011 | US20110112058 Novel modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 05/12/2011 | US20110112054 Organophosphorous Compounds for the Activation of Gamma/Delta T Cells |
| 05/12/2011 | US20110112049 Methods of preventing or treating diseases and conditions using complex carbohydrates |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112011 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111493 Compositions and Methods For Inhibiting Expression Of A Target Gene |
| 05/12/2011 | US20110111017 Use of immunogenic compositions for the treatment or prevention of pathogen infections |